Rasagiline (Ascend Laboratories, LLC)
Welcome to the PulseAid listing for the Rasagiline drug offered from Ascend Laboratories, LLC. This Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ascend Laboratories, LLC |
NON-PROPRIETARY NAME: | Rasagiline |
SUBSTANCE NAME: | RASAGILINE MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-10-30 |
END MARKETING DATE: | 0000-00-00 |
Rasagiline HUMAN PRESCRIPTION DRUG Details:
Item Description | Rasagiline from Ascend Laboratories, LLC |
LABELER NAME: | Ascend Laboratories, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2017-10-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67877-259_f21a6e0e-6778-4871-9d11-756a969f0e24 |
PRODUCT NDC: | 67877-259 |
APPLICATION NUMBER: | ANDA201889 |
Other RASAGILINE MESYLATE Pharmaceutical Manufacturers / Labelers: